The Impact of Targeted Molecular Therapies on the Level of Renal Cell Carcinoma Vena Caval Tumor Thrombus

Abstract Background Targeted molecular therapies (TMTs) previously have demonstrated oncologic activity in renal cell carcinoma (RCC) by reducing the size of primary tumors and metastases. Objective To assess the cytoreductive effect of TMTs on inferior vena cava tumor thrombi. Design, setting, and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European urology 2011-06, Vol.59 (6), p.912-918
Hauptverfasser: Cost, Nicholas G, Delacroix, Scott E, Sleeper, Joshua P, Smith, Paul J, Youssef, Ramy F, Chapin, Brian F, Karam, Jose A, Culp, Stephen, Abel, E. Jason, Brugarolas, James, Raj, Ganesh V, Sagalowsky, Arthur I, Wood, Christopher G, Margulis, Vitaly
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!